- Home
- HBIO vs IGA Comparison
HBIO vs IGA Comparison
Compare HBIO & IGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HBIO
- IGA
- Stock Information
- Founded
- HBIO 1901
- IGA 2005
- Country
- HBIO United States
- IGA United States
- Employees
- HBIO N/A
- IGA N/A
- Industry
- HBIO Biotechnology: Laboratory Analytical Instruments
- IGA Investment Managers
- Sector
- HBIO Industrials
- IGA Finance
- Exchange
- HBIO Nasdaq
- IGA Nasdaq
- Market Cap
- HBIO 117.7M
- IGA 143.3M
- IPO Year
- HBIO 2000
- IGA N/A
- Fundamental
- Price
- HBIO $2.94
- IGA $9.47
- Analyst Decision
- HBIO
- IGA
- Analyst Count
- HBIO 0
- IGA 0
- Target Price
- HBIO N/A
- IGA N/A
- AVG Volume (30 Days)
- HBIO 88.1K
- IGA 42.3K
- Earning Date
- HBIO 11-05-2024
- IGA 01-01-0001
- Dividend Yield
- HBIO N/A
- IGA 8.93%
- EPS Growth
- HBIO N/A
- IGA N/A
- EPS
- HBIO N/A
- IGA N/A
- Revenue
- HBIO $101,125,000.00
- IGA N/A
- Revenue This Year
- HBIO N/A
- IGA N/A
- Revenue Next Year
- HBIO $2.68
- IGA N/A
- P/E Ratio
- HBIO N/A
- IGA N/A
- Revenue Growth
- HBIO N/A
- IGA N/A
- 52 Week Low
- HBIO $2.61
- IGA $7.77
- 52 Week High
- HBIO $5.56
- IGA $8.88
- Technical
- Relative Strength Index (RSI)
- HBIO 47.55
- IGA 59.41
- Support Level
- HBIO $2.65
- IGA $9.25
- Resistance Level
- HBIO $3.14
- IGA $9.48
- Average True Range (ATR)
- HBIO 0.17
- IGA 0.10
- MACD
- HBIO 0.00
- IGA -0.01
- Stochastic Oscillator
- HBIO 33.33
- IGA 77.08
About HBIO Harvard Bioscience Inc.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab.. The majority of its revenue comes from the United States.
About IGA Voya Global Advantage and Premium Opportunity Fund of Beneficial Interest
Voya Global Advantage and Premium Opportunity Fund is a United States-based diversified, closed-end management investment company. The fund has two investment objectives. Its primary objective is to provide a high level of income, while the secondary objective is to seek capital appreciation. To achieve these objectives, the fund invests at least 80% of its managed assets in a portfolio of common stocks from various countries around the world, including the United States. Additionally, it uses an integrated derivatives strategy.